All In Biotech

Drug Trial Radar · NCT05260385

To Evaluate KC1036 in the Patients with Advanced Digestive System Tumors

A Phase Ib / II Study to Evaluate the Efficacy and Safety of KC1036 in the Patients with Advanced Recurrent or Metastatic Digestive System Tumors

Last checked: Nov 19, 2026Latest source record: Oct 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

133

Planned (sponsor's estimate)

Start

Jan 24, 2022

Primary completion

Oct 30, 2025

Study completion Dec 30, 2025

Sponsor

Sponsor type
Industry
First posted
Mar 2, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the preliminary efficacy, safety, tolerability and pharmacokinetics of KC1036 in participants with advanced recurrent or metastatic digestive system tumors.

Conditions

  • Digestive System Tumors

Interventions

  • KC1036Drug

    KC1036 are administered orally QD or BID in 21-day cycles.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response Rate (ORR)Time frame: approximately 2 year.

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Cancer Hospital, Chinese Academy of Medical Sciences

    Beijing, China · Recruiting

  • The first affiliated hospital of bengbu medical college

    Bengbu, China · Recruiting

  • Chongqing University Three Gorges Hospital

    Chongqing, China · Recruiting

  • Fujian Cancer Hospital

    Fujian, China · Recruiting

  • Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University

    Henan, China · Recruiting

  • The First Affiliated Hospital of Xinxiang Medical University

    Henan, China · Recruiting

  • Hubei Cancer Hospital

    Hubei, China · Recruiting

  • Union Hospital Tongji Medical College Huazhong University of Science and Technologe

    Hubei, China · Recruiting

  • Shandong Cancer Hospital & Institute

    Shandong, China · Recruiting

  • Shanghai Chest Hospital

    Shanghai, China · Recruiting

  • Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen Center

    Shenzhen, China · Recruiting

  • Tianjin Medical University Cancer Institute &Hospital

    Tianjin, China · Recruiting

  • The Second Affiliated Hospital Zhejiang University School of Medicine

    Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.